Conversely, residual dormant tumor cells after treatment were reported to be associated with tumor heterogeneity [63], whereas intratumor heterogeneity was less in the high NR2F1-expressing breast tumors in TCGA. The gene discussed is NR2F1; the disease is neoplasm.